APX-2048

N/A

Report date: 2025/01/26 15:06:58
NME

Base Information

Drug NameAPX-2048
Drug Alias NameAPX-2048
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA-(apurinic or apyrimidinic site) lyase inhibitors
TargetsDNA-(apurinic or apyrimidinic site) lyase
Therapy Area/Indications +[1N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesApexian Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active Indications +[1N/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A